Microarray Analysis of Gene Expression in Liver Tumors - Full Text View

Microarray Analysis of Gene Expression in Liver Tumors

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Stanford University National Institutes of Health (NIH)
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00373737

Purpose

This study aims to study the gene expression profiles of liver tumors to help us understand their biology, and to find new tumor and treatment markers for liver cancer.

Condition

Liver Cancer

MedlinePlus related topics:

Cancer Liver Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective

Official Title:	Microarray Analysis of Gene Expression in Liver Tumors

Further study details as provided by Stanford University:

Estimated Enrollment:	300
Study Start Date:	May 1999

Detailed Description:

The purpose of this research is to study of the biologic features of liver tissue (by studying their gene expression profiles), so that we can increase our understanding of the processes involved in liver cancer development and growth. This may allow us to identify more effective ways of diagnosing, treating, and predicting the outcome of patients with liver cancer.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:Inclusion Criteria:

Patients with liver tumors undergoing partial liver resection, open liver biopsy, and patients undergoing liver transplantation with or without liver tumors at Stanford University
Patients older than 18

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00373737

Locations


United States, California
	Stanford University School of Medicine
	Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

National Institutes of Health (NIH)

Investigators


Principal Investigator:	Samuel So	Stanford University

More Information

Study ID Numbers:	HEP0005, 76710, HEP0005, NCT00373737
First Received:	September 6, 2006
Last Updated:	July 11, 2008
ClinicalTrials.gov Identifier:	NCT00373737
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Liver Neoplasms

Liver Diseases

Digestive System Diseases

Digestive System Neoplasms

Liver neoplasms

Gastrointestinal Neoplasms

Hepatocellular carcinoma

Additional relevant MeSH terms:

Neoplasms

Neoplasms by Site

ClinicalTrials.gov processed this record on October 16, 2008